Results:
The frequencies of SLCO1B1 521T>C between men and women were statistically significant (SLCO1B1 521TT, χ 2 = 8.431, P = .004; SLCO1B1 521TC, χ 2 = 7.436, P = .007). The frequencies of haplotypes *1b/*1b (40.07%) and *1a/*1b (32.56%) of SLCO1B1 gene accounted for 72.63%, followed by *1b/*15(14.40%), *1a/*1a (5.82%), *1a/*15 (5.57%), *15/*15 (1.45%), and *1a/*5 (0.12%). The frequencies of haplotypes *1a/*15 and *1b/*1b of SLCO1B1 gene between men and women were statistically significant (*1a/*15, χ 2 = 6.789, P = .009; *1b/*1b, χ 2 = 3.998, P = .004). In this study, genotype ɛ3/ɛ3 accounted for 69.04%, followed by ɛ3/ɛ4 (16.19%) , ɛ2/ɛ3 (11.60%), ɛ2/ɛ4 (1.35%), ɛ4/ɛ4 (1.08%), and ɛ2/ɛ2 (0.74%) in all subjects, in which ɛ3 had the greatest allele frequency (82.93%), followed by ɛ4 (9.85%) and ɛ2 (7.22%). We found that 47 subjects carrying the SLCO1B1 521 (CC) polymorphism who had not any myopathy caused by statins.
Conclusions:
We analyzed the SLCO1B1 and APOE gene polymorphisms in the Hakka population of southern China. This study provides a reference for the individualized meditation for Hakka population in this area.
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SLCO1B1 genetic mutation appears to be statin-specific, that is highest risks with simvastatin and atorvastatin and lowest with pravastatin and rosuvastatin. 5, 6 Apolipoprotein E (ApoE) is an important intrinsic factor affecting blood lipid levels, and ApoE polymorphism is considered to be a susceptible candidate for hyperlipidemia and atherosclerosis, which is related to the efficacy of statins. Regarding the high importance of SLCO1B1 and APOE pharmacogenes in drug dosing of statins, it is important to evaluate the SLCO1B1
and APOE genotypes in different ethnic populations. Meizhou, located at the junction of Fujian, Guangdong, and Jiangxi provinces in China, covers area of 15 876 km 2 and possesses a population of 5.44 million.
The vast majority people lived in Meizhou are Hakka, which is an intriguing Han Chinese population in northern China. 24 In this region, there is no report on the SLCO1B1 and APOE genetic polymorphisms.
The purpose of this study was to analyze the SLCO1B1 and APOE genetic polymorphisms in the Hakka population of southern China and provide a theoretical basis for the prevention and treatment of coronary heart disease.
| MATERIALS AND METHODS

| Study subjects
A total of 3249 subjects including 2019 males and 1230 females 
| Plasma lipid measurements
About 3 mL of blood samples for the measurement of lipid levels was obtained from subjects, and plasma was separated and stored at −80°C till further analysis. Plasma levels of triglyceride (TG), total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), apolipoprotein A1 (Apo-A1), and apolipoprotein B (Apo-B) were measured.
| DNA extraction and genotyping
Blood samples were stored in 2-mL vacuum tubes containing ethylenediaminetatraacetic acid (EDTA) from participants. Genomic DNA was extracted from the blood of subjects using QIAamp DNA Blood Mini Kit (Qiagen, Germany) following the manufacturer's instructions, and DNA concentration was quantified using NanoDrop 2000 TM Spectrophotometer (ThermoFisher Scientific, Waltham, MA).
Polymerase chain reaction was performed according to the following protocol: 37°C for 10 minutes, predenaturation at 95°C for 5 minutes, followed by 40 cycles at 95°C for 15 seconds, and 60°C for 60 seconds.
The fluorescence signals were collected as FAM (SLCO1B1*1b 388A, SLCO1B1*5 521T, ApoE2 526C, ApoE4 388T) and VIC (SLCO1B1*1b 388G, SLCO1B1*5 521C, ApoE2 526T, ApoE4 388C) and ROX (internal standard) (PCR-fluorescence probe method) (Youzhiyou Medical Technology Co., Ltd, Wuhan, Hubei, China).
| Statistical analysis
SPSS statistical software version 19.0 was used for data analysis.
Data were reported as the means ± SD. Chi-square and ANOVA tests were used to analyze the associations between variant SLCO1B1 and APOE genotypes and clinical characteristics. Statistical significance was set at a P < .05.
| RESULTS
| Population characteristics
A total of 3249 subjects, 2019 (62.14%) men and 1230 (37.86%) women, were recruited in the study. The mean age was 65.50 ± 11.69 years, which was 64.95 ± 11.73 years in men and 66.40 ± 11.57 in women.
The difference of blood lipid level between men and women was statistically significant as shown in Table 1 .
| Genotype and haplotype frequencies
The frequencies of SLCO1B1 521T>C between men and women were statistically significant (SLCO1B1 521TT, χ 2 = 8.431, P = .004; SLCO1B1 521TC, χ 2 = 7.436, P = .007). Genotype and allele frequencies of SLCO1B1 388A>G and 521T>C in the Hakka population in our research are shown in Table 2 .
The frequencies of haplotypes *1b/*1b (40.07%) and *1a/*1b (32.56%) of SLCO1B1 gene accounted for 72.63%, followed by *1b/*15(14.40%), *1a/*1a (5.82%), *1a/*15 (5.57%), *15/*15 (1.45%), and *1a/*5 (0.12%). The frequencies of haplotypes *1a/*15 and *1b/*1b of SLCO1B1 gene between men and women were statistically significant (*1a/*15, χ 2 =6.789, P = 0.009; *1b/*1b, χ 2 = 3.998, P = .004) as shown in Table 3 .
In this study, genotype ɛ3/ɛ3 accounted for 69.04%, followed by ɛ3/ɛ4 (16.19%), ɛ2/ɛ3 (11.60%), ɛ2/ɛ4 (1.35%), ɛ4/ɛ4 (1.08%), and ɛ2/ɛ2 (0.74%) in all subjects, in which ɛ3 had the greatest allele frequency (82.93%), followed by ɛ4 (9.85%) and ɛ2 (7.22%). Detailed data are listed in Table 4 .
| Effect of SLCO1B1 521 (CC) polymorphism on side effects used statins
Presence of SLCO1B1 521C variant can lead to increased systemic statin concentrations and is strongly associated with statin-induced myopathy. In this study, we detected 47 subjects carrying the SLCO1B1 521 (CC) polymorphism. We checked their medical records and did not find any myopathy caused by statins. The results are shown in Table 5 . 
| DISCUSSION
Since the advent of statins, it has become the most widely used The SLCO1B1 388A>G SNP has a frequency of 25%-30% in Caucasians, 29, 30 in which 521T>C SNP was 15%-20%. 29, [31] [32] [33] The mutation allele frequency of SLCO1B1 388A>G was 74.99% (74.57%
in male and 75.69% in female), and 521T>C was 11.50% (12.38% in male and 10.04% in female) in the Hakka population in our research. The results were similar to the study results of Liu et al, 34 the allele frequency of SLCO1B1 388A>G was higher in Chinese
Han than in Caucasians, while 521T>C was lower. The frequencies of haplotypes *1b/*1b (40.07%) and *1a/*1b (32.56%) of SLCO1B1 gene accounted for 72.63%, followed by *1b/*15 (14.40%), *1a/*1a (5.82%), *1a/*15 (5.57%), *15/*15 (1.45%), and *1a/*5 (0.12%). Our results were consistent with the previous researches in Chinese Han population. [35] [36] [37] In the Chinese population, genotype ɛ3/ɛ3 is the commonest one, while allele ɛ3 is the commonest allele. Our results confirmed previous research conclusions. In this study, genotype ɛ3/ɛ3 accounted for 69.04%, followed by ɛ3/ɛ4 (16.19%), ɛ2/ɛ3 (11.60%), ɛ2/ɛ4 (1.35%), ɛ4/ ɛ4 (1.08%), and ɛ2/ɛ2 (0.74%) in all subjects, in which ɛ3 had the greatest allele frequency (82.93%), followed by ɛ4 (9.85%) and ɛ2 (7.22%).
It showed that the frequencies of APOE allele in the Hakka population were similar to those in the Chinese-Northeast, 38 Chinese-Jiangsu
Han, 39 and Chinese-Kunming Han populations, 40 in which ɛ4 allele in the Hakka population was lower than in the Chinese-Shanghai population. 41 Comparison of our results to the geographically neighboring countries
showed that the frequency of ɛ4 allele in the Hakka population was lower than in the Japanese, 42, 43 Mongolian, 16 Vietnamese, 44 Malay, 45 Javanese, 45 and Korean 46 populations, in which ɛ4 gene carriers have a higher risk of cardiovascular disease. 22, 47, 48 This is the first study to report the frequencies of the most com- T A B L E 5 Forty-seven subjects with SLCO1B1 521(CC) polymorphism and used drugs and doses of statins 51 The application of NGS to study gene variants with the efficacy and safety of statins is also the focus of our next research direction.
